1.1700 +0.04 (3.54%)
Pre-Market: 4:06AM EST
One Kendall Square
Suite B14402
Cambridge, MA 02139
United States
617 863 5500
http://www.invivotherapeutics.com
Sector(s):Â Healthcare
Industry:Â Biotechnology
Full Time Employees:Â 6
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Richard M. Toselli | Pres, CEO, Chief Medical Officer & Director | 1.22M | N/A | 1958 |
Mr. Richard C. Christopher | CFO & Treasurer | 553.07k | N/A | 1970 |
Dr. Robert S. Langer Jr. | Co-Founder & Member of Scientific Advisory Board | N/A | N/A | 1949 |
Dr. Joseph Philip Vacanti | Co-Founder | N/A | N/A | 1949 |
Mr. William D'Agostino PE | Sr. VP of Operations | N/A | N/A | N/A |
Ms. Heather Hamel | VP of Legal Affairs & Bus. Devel. and Corp. Sec. | N/A | N/A | N/A |
Dr. Louis Vaickus | Consultant | N/A | N/A | 1953 |
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. The company is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for the implantation at the site of injury within a spinal cord. InVivo Therapeutics Holdings Corp. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
InVivo Therapeutics Holdings Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.